TSXV:RHT.H - Post by User
Comment by
EdinColoradoon Sep 28, 2023 11:33am
86 Views
Post# 35659423
RE:RE:RE:sums it up ...
RE:RE:RE:sums it up ... Certainly no arguments about pathology. Lisa's pathological overhyping of this company with outrageous predictions with firm dates never met is what has given investors the bath we are in. That overpromising goes well beyond optimism.
But there is a balance side. To produce the actual substance—the technical knowledge needed to assemble the hardware and software systems that really makes telemedicine effective requires brilliance. Lisa has proven she can build and manage building that. That is now why Reliq is able to get the contracts. The medical establishment understands the benefits of this particular hardware and software in a way most investors on this board cannot.
To get us to this place reqired years of grunt work and learning from hard knocks. Quietly going about the grunt work needed to produce the remarkable and punctuated breakthrough is how good science and good technology gets done. When showbiz overhyping gets into interfering with the grunt work, it produces nuisance interference. We investors would have been in a much better place without the showbiz.
I think we are nearly arrived at a breakthrough position. The company has the product needed to benefit both health providers and patients and it took some genius to bring everything together through the grunt work to get us to where we are on the technical side. Despite the showbiz that has murdered the stock price, the substance is stil here.